Genetic polymorphisms of the renin-angiotensin system and obesity-related metabolic changes in response to low-energy diets in obese women

Nutrition

Volumn 27, Issue 1, 2011, Pages 34-39

  Hamada, Taku ^a   Kotani, Kazuhiko ^b   Nagai, Narumi ^c   Tsuzaki, Kokoro ^e   Sano, Yoshiko ^e   Matsuoka, Yukiyo ^e   Fujibayashi, Mami ^d   Kiyohara, Natsuki ^d   Tanaka, Seitaro ^d   Yoshimura, Makiko ^f   Egawa, Kahori ^f   Kitagawa, Yoshinori ^f   Kiso, Yoshinobu ^f   Moritani, Toshio ^d   Sakane, Naoki ^e  

^a OSAKA UNIVERSITY OF HEALTH AND SPORT SCIENCES   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF HYOGO   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^f Suntory Wellness Limited Research Center   (Japan)

Author keywords

Metabolism; Nutrition; Polymorphism; Renin angiotensin; Weight reduction

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; CARBOHYDRATE; DIPEPTIDYL CARBOXYPEPTIDASE; FAT; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY FAT; CALORIC RESTRICTION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DIPEPTIDYL CARBOXYPEPTIDASE GENE; FEMALE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; INDEL MUTATION; LIPID OXIDATION; METABOLIC DISORDER; MUTATIONAL ANALYSIS; OBESITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; WEIGHT REDUCTION;

ADIPOSE TISSUE; ADULT; BLOOD PRESSURE; CALORIC RESTRICTION; CARBOHYDRATE METABOLISM; CHOLESTEROL, LDL; DIET, REDUCING; FEMALE; GENOTYPE; HUMANS; LIPID PEROXIDATION; MIDDLE AGED; OBESITY; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN-ANGIOTENSIN SYSTEM;

EID: 78649937158     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2009.10.012     Document Type: Article

References (37)

1. Kramer H., Wu X., Kan D., Luke A., Zhu X., Adeyemo A., McKenzie C., Cooper R. Angiotensin-converting enzyme gene polymorphisms and obesity: an examination of three black populations. Obes Res 2005, 13:823-828.
2. Meguid M.M., Glade M.J., Middleton F.A. Weight regain after Roux-en-Y: a significant 20% complication related to PYY. Nutrition 2008, 24:832-842.
3. Balkau B., Deanfield J.E., Després J.P., Bassand J.P., Fox K.A., Smith S.C., Barter P., Tan C.E., Van Gaal L., Wittchen H.U., Massien C., Haffner S.M. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 2007, 116:1942-1951.
4. Tentolouris N., Liatis S., Katsilambros N. Sympathetic system activity in obesity and metabolic syndrome. Ann NY Acad Sci 2006, 1083:129-152.
5. The Lifestyle Disease Countermeasure division of Ministry of Health Labor and Welfare. The 2006 Annual report of the national health and nutrition survey in Japan. pp. 9-10.
6. Finer N. Low-calorie diets and sustained weight loss. Obes Res 2001, 9. 290S-4.
7. Astrup A., Caterson I., Zelissen P., Guy-Grand B., Carruba M., Levy B., Sun X., Fitchet M. Topiramate: long-term maintenance of weight loss induced by a low-calorie diet in obese subjects. Obes Res 2004, 12:1658-1669.
8. Strazzullo P., Iacone R., Iacoviello L., Russo O., Barba G., Russo P., D'Orazio A., Barbato A., Cappuccio F.P., Farinaro E., Siani A. Olivetti Prospective Heart Study. Genetic variation in the renin-angiotensin system and abdominal adiposity in men: the Olivetti Prospective Heart Study. Ann Intern Med 2003, 138:17-23.
9. Zhang L., Miyaki K., Araki J., Song Y., Kimura T., Omae K., Muramatsu M. Interaction of angiotensin I-converting enzyme insertion-deletion polymorphism and daily salt intake influences hypertension in Japanese men. Hypertens Res 2006, 29:751-758.
10. Buraczyńska M., Pijanowski Z., Spasiewicz D., Nowicka T., Sodolski T., Widomska-Czekajska T., Ksiazek A. Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease. Kardiol Pol 2003, 58:1-9.
11. Kostis J.B., Wilson A.C., Hooper W.C., Harrison K.W., Philipp C.S., Appel L.J., Espeland M.A., Folmar S., Johnson K.C. Association of angiotensin-converting enzyme DD genotype with blood pressure sensitivity to weight loss. Am Heart J 2002, 144:625-629.
12. Cambien F., Poirier O., Lecerf L., Evans A., Cambou J.P., Arveiler D., Luc G., Bard J.M., Bara L., Ricard S., Tiret L., Amouyel P., Gelas F.A., Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992, 359:641-644.
13. Jin J.J., Nakura J., Wu Z., Yamamoto M., Abe M., Chen Y., Tabara Y., Yamamoto Y., Igase M., Bo X., Kohara K., Miki T. Association of angiotensin II type 2 receptor gene variant with hypertension. Hypertens Res 2003, 26:547-552.
14. Martin M.M., Elton T.S. The sequence and genomic organization of the human type 2 angiotensin II receptor. Biochem Biophys Res Commun 1995, 209:554-562.
15. Deinum J., van Gool J.M., Kofflard M.J., ten Cate F.J., Danser A.H. Angiotensin II type 2 receptors and cardiac hypertrophy in women with hypertrophic cardiomyopathy. Hypertension 2001, 38:1278-1281.
16. Aoki S., Mukae S., Itoh S., Sato R., Nishio K., Iwata T., Katagiri T. The genetic factor in acute myocardial infarction with hypertension. Jpn Circ J 2001, 65:621-626.
17. Yamada Y., Izawa H., Ichihara S., Takatsu F., Ishihara H., Hirayama H., Sone T., Tanaka M., Yokota M. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002, 347:1916-1923.
18. New Criteria for Obesity Disease. Japan Cir J 2002, 66:987-992. The Examination Committee of Criteria for Obesity Disease in Japan, Japan Society for the Study of Obesity.
19. Lusk G. Animal calorimetory: analysis of the oxidation of mixtures of carbohydrate and fat. J Biol Chem 1924, 59:41-42.
20. Nagai N., Sakane N., Ueno L.M., Hamada T., Moritani T. The -3826 A → G variant of the uncoupling protein-1 gene diminishes postprandial thermogenesis after a high fat meal in healthy boys. J Clin Endocrinol Metab 2003, 88:5661-5667.
21. *Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007, 39:175-191.
22. Blackburn G. Effect of degree of weight loss on health benefits. Obes Res 1995, S2:211-216.
23. Krebs J.D., Evans S., Cooney L., Mishra G.D., Fruhbeck G., Finer N., Jebb S.A. Changes in risk factors for cardiovascular disease with body fat loss in obese women. Diabetes Obes Metab 2002, 4:379-387.
24. Barbato K.B., Martins Rde C., Rodrigues Mde L., Braga J.U., Francischetti E.A., Genelhu V. Effects of greater-than-5% weight reduction on hemodynamic, metabolic and neuroendocrine profiles of grade I obese subjects. Arq Bras Cardiol 2006, 87:12-21.
25. Engeli S., Gorzelniak K., Kreutz R., Runkel N., Distler A., Sharma A.M. Co-expression of renin-angiotensin system genes in human adipose tissue. J Hypertens 1999, 17:555-560.
26. Schling P., Mallow H., Trindl A., Löffler G. Evidence for a local renin angiotensin system in primary cultured human preadipocytes. Int J Obes Relat Metab Disord 1999, 23:336-341.
27. Ailhaud G., Fukamizu A., Massiera F., Negrel R., Saint-Marc P., Teboul M. Angiotensinogen, angiotensin II and adipose tissue development. Int J Obes Relat Metab Disord 2000, 24:S33-S35.
28. Engeli S., Negrel R., Sharma A.M. Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension 2000, 35:1270-1277.
29. Campbell D.J., Rong P., Kladis A., Rees B., Ganten D., Skinner S.L. Angiotensin and bradykinin peptides in the TGR(mRen-2)27 rat. Hypertension 1995, 26:843-845.
30. Crandall D.L., Herzlinger H.E., Saunders B.D., Armellino D.C., Kral J.G. Distribution of angiotensin II receptors in rat and human adipocytes. J Lipid Res 1994, 35:1378-1385.
31. Jones A., Dhamrait S.S., Payne J.R., Hawe E., Li P., Toor I.S., Luong L., Wootton P.T., Miller G.J., Humphries S.E., Montgomery H.E. Genetic variants of angiotensin II receptors and cardiovascular risk in hypertension. Hypertension 2003, 42:500-506.
32. Kuznetsova T., Staessen J.A., Thijs L., Kunath C., Olszanecka A., Ryabikov A., Tikhonoff V., Stolarz K., Bianchi G., Casiglia E., Fagard R., Brand-Herrmann S.M., Kawecka-Jaszcz K., Malyutina S., Nikitin Y., Brand E. Left ventricular mass in relation to genetic variation in angiotensin II receptors, renin system genes, and sodium excretion. Circulation 2004, 110:2644-2650.
33. Ito M., Soma M., Izumi Y., Kanmatsuse K. Effects of long-term treatment with angiotensin-converting enzyme inhibitor on angiotensin II and prostacyclin release from mesenteric arteries in spontaneously hypertensive rats. Prostaglandins Leukot Essent Fatty Acids 1995, 53:359-363.
34. Tsuchida S., Matsusaka T., Chen X., Okubo S., Niimura F., Nishimura H., Fogo A., Utsunomiya H., Inagami T., Ichikawa I. Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes. J Clin Invest 1998, 101:755-760.
35. Ito M., Oliverio M.I., Mannon P.J., Best C.F., Maeda N., Smithies O., Coffman T.M. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci USA 1995, 92:3521-3525.
36. Hein L., Barsh G.S., Pratt R.E., Dzau V.J., Kobilka B.K. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 1995, 377:744-747.
37. Ichiki T., Labosky P.A., Shiota C., Okuyama S., Imagawa Y., Fogo A., Niimura F., Ichikawa I., Hogan B.L., Inagami T. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995, 377:748-750.